Annual Shareholders Equity
$140.48 M
+$22.09 M+18.65%
31 December 2023
Summary:
Inozyme Pharma annual stockholders equity is currently $140.48 million, with the most recent change of +$22.09 million (+18.65%) on 31 December 2023. During the last 3 years, it has fallen by -$17.62 million (-11.15%). INZY annual shareholders equity is now -11.15% below its all-time high of $158.10 million, reached on 31 December 2020.INZY Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$82.79 M
-$11.63 M-12.32%
30 September 2024
Summary:
Inozyme Pharma quarterly stockholders equity is currently $82.79 million, with the most recent change of -$11.63 million (-12.32%) on 30 September 2024. Over the past year, it has dropped by -$77.42 million (-48.33%). INZY quarterly shareholders equity is now -50.70% below its all-time high of $167.92 million, reached on 30 September 2020.INZY Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INZY Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.6% | -48.3% |
| 3 y3 years | -11.2% | -34.3% |
| 5 y5 years | +1112.5% | - |
INZY Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -11.2% | +28.6% | -48.3% | at low |
| 5 y | 5 years | -11.2% | +522.9% | -50.7% | +265.5% |
| alltime | all time | -11.2% | +522.9% | -50.7% | +265.5% |
Inozyme Pharma Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $82.79 M(-12.3%) |
| June 2024 | - | $94.42 M(-20.5%) |
| Mar 2024 | - | $118.84 M(-15.4%) |
| Dec 2023 | $140.48 M(+18.7%) | $140.48 M(-12.3%) |
| Sept 2023 | - | $160.21 M(+51.7%) |
| June 2023 | - | $105.59 M(+2.2%) |
| Mar 2023 | - | $103.35 M(-12.7%) |
| Dec 2022 | $118.39 M | $118.39 M(-12.2%) |
| Sept 2022 | - | $134.78 M(-9.7%) |
| June 2022 | - | $149.18 M(+58.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $94.23 M(-13.8%) |
| Dec 2021 | $109.27 M(-30.9%) | $109.27 M(-13.3%) |
| Sept 2021 | - | $125.97 M(-8.9%) |
| June 2021 | - | $138.27 M(-7.1%) |
| Mar 2021 | - | $148.89 M(-5.8%) |
| Dec 2020 | $158.10 M(-575.9%) | $158.10 M(-5.8%) |
| Sept 2020 | - | $167.92 M(-435.7%) |
| June 2020 | - | -$50.02 M(-170.6%) |
| Mar 2020 | - | $70.83 M(-313.2%) |
| Dec 2019 | -$33.22 M(+139.4%) | -$33.22 M |
| Dec 2018 | -$13.88 M | - |
FAQ
- What is Inozyme Pharma annual stockholders equity?
- What is the all time high annual shareholders equity for Inozyme Pharma?
- What is Inozyme Pharma annual shareholders equity year-on-year change?
- What is Inozyme Pharma quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Inozyme Pharma?
- What is Inozyme Pharma quarterly shareholders equity year-on-year change?
What is Inozyme Pharma annual stockholders equity?
The current annual shareholders equity of INZY is $140.48 M
What is the all time high annual shareholders equity for Inozyme Pharma?
Inozyme Pharma all-time high annual stockholders equity is $158.10 M
What is Inozyme Pharma annual shareholders equity year-on-year change?
Over the past year, INZY annual stockholders equity has changed by +$22.09 M (+18.65%)
What is Inozyme Pharma quarterly stockholders equity?
The current quarterly shareholders equity of INZY is $82.79 M
What is the all time high quarterly shareholders equity for Inozyme Pharma?
Inozyme Pharma all-time high quarterly stockholders equity is $167.92 M
What is Inozyme Pharma quarterly shareholders equity year-on-year change?
Over the past year, INZY quarterly stockholders equity has changed by -$77.42 M (-48.33%)